ReviewCurrent treatment options in oncology2026
Local Recurrence After Pancreatic Cancer Resection: A Multidisciplinary Review of Risk Factors and Potential Causes, Diagnostic Innovations, Emerging Therapeutic Frontiers, and Prevention Strategies.
Review in Current treatment options in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
opinion statementPancreatic cancer represents a malignant tumor of the digestive system with an inferior clinical prognosis, primarily attributable to the challenges in early diagnosis that preclude surgery-based treatment for most patients. Furthermore, the high postoperative recurrence rate significantly limits long-term survival in surgical candidates. Among patients experiencing recurrence after pancreatic cancer resection, local recurrence emerges as one of the most prevalent patterns. Early detection remains equally critical for recurrent cases, as selected patients undergoing potentially curative therapy for localized recurrence demonstrate that they can still extend post-recurrence survival. This comprehensive review synthesizes current evidence regarding the pathogenesis, risk determinants, diagnostic approaches, therapeutic interventions, and preventive measures for local recurrence following pancreatic cancer surgery. Emphasis is placed on analyzing the potential etiopathogenetic mechanisms and risk determinants for postoperative local recurrence, including tumor biology characteristics, tumor microenvironment interactions, and clinicopathological influences, providing foundations for preventive strategies. Emerging diagnostic modalities, particularly advanced imaging, and histopathological techniques, enhance early detection of locoregional recurrence. The review further examines evolving treatment paradigms encompassing precision radiotherapy, targeted systemic therapies, and innovative immunotherapeutic approaches for recurrent disease management. By integrating multidisciplinary perspectives, this work aims to inform optimized preventive approaches, surveillance and diagnostic protocols, and advance personalized management strategies for postoperative local recurrence in patients with pancreatic cancer.
Indexed as
Identifiers
42550364What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.